Fluocinonide NDC 70752-154

NDC codes

FDA NDC Directory

Product NDC (as listed)70752-154Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70752-0154Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70752-154-05	70752015405	1 BOTTLE in 1 CARTON (70752-154-05) / 60 mL in 1 BOTTLEMarketed from Mar 15, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: QUAGEN PHARMACEUTICALS LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216389
Marketing start: Mar 15, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70752-154_553fcfd7-2fe8-4538-9fe8-d42a35ab2d48SPL ID 553fcfd7-2fe8-4538-9fe8-d42a35ab2d48SPL set ID 272a4467-b5f8-430b-8fab-7fbb07dc8114RxCUI 310364UNII 2W4A77YPANUPC 0370752154055
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470752015405 followed by a unit qualifier and the quantity

Package 70752-0154-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluocinonide topical solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)